Background Immunoassay methods for urinary free cortisol (UFC) lack specificity, and many procedures have not been fully evaluated for routine use. In the current study we evaluated the Bayer ADVIA Centaur extraction UFC immunoassay and compared results to those obtained by a specific gas chromatography-mass spectrometry (GC-MS) method.
Introduction
Urine contains a complex mixture of steroids and steroid metabolites. Determination of urinary free cortisol (UFC) within this mixture is di¤cult, and most routine immunoassay methods lack speci¢city. A report by UK NEQAS 1 showed that immunoassay methods had a positive bias compared to a gas chromatography-mass spectrometry (GC-MS) reference method, with the all lab-trimmed mean averaging 63.1% higher than the GC-MS method.
In addition, most UFC immunoassays are carried out using automated serum cortisol assays, and are often not fully validated for urine. The poor performance of some procedures has recently been highlighted by Murphy. 2 In the current study, we evaluated the Bayer ADVIA Centaur extraction UFC method, and compared results with those obtained by a speci¢c GC-MS method.
Materials and methods
Steroids were purchased from Sigma (Poole, UK). Urine reconstruction bu¡er was manufactured by Chiron Diagnostics (now Bayer plc, Newbury, UK).
Steroid-free serum was from HD supplies (Aylesbury, UK). Solvents were from BDH (Poole, UK).
The Bayer ADVIA Centaur extraction UFC method makes use of the serum cortisol assay. Cortisol was extracted from urine (0.5 mL) with dichloromethane (2.5 mL). The dried extract was redissolved in urine reconstruction bu¡er, or steroid-free serum for analysis, to give 50% dilution. Cross-reactivities were calculated from displacement curves, at 50% reduction in assay response, using the equation:
The inter-assay precision of the Centaur cortisol method at means of 82, 572 and 883 is 12.3%, 6.8% and 6.4%, respectively (nˆ20).
The GC-MS method was a modi¢cation of the method of Shackleton, 3 using a ThermoQuest GCQ 2 plus Benchtop Ion-Trap GCMS system (ThermoQuest, TX, USA). The method has a linear range of 14-2500 nmol/ L, a detection limit of 14 nmol/ L and 98% recovery of added cortisol. Inter-assay coe¤cient of variation (CV), at means of 16.5 and 139.5 nmol/ L, was 7.9% and 11.2%, respectively. Correction of procedural losses was achieved using a structurally Short Report similar non-naturally occurring steroid (allo-tetrahydrodeoxycorticosterone).
For comparison studies, patients' samples (nˆ31) were selected on the basis of elevated or borderline UFC measurements, as determined by the Bayer Immuno-1 UFC method.
Results and discussion

Speci city
The cross-reactivities of cortisone, 11-deoxycortisol and 6b-hydroxycortisol as determined by the Bayer ADVIA Centaur cortisol assay were 44%, 18% and 2.5%, respectively. These steroids are structurally similar to cortisol, and are present in urine at similar or higher concentrations. Exogenous steroid, prednisolone, had a cross-reactivity of approximately 50%. These cross-reactivities were under-estimated in the manufacturer's assay literature as 27%, 7.4%, 7.3% and 2.4%, for prednisolone, cortisone, 11-deoxycortisol and 6b-hydroxycortisol, respectively. The cross-reactivities detailed by the manufacturer were determined at concentrations higher than physiological and pathological levels, and beyond the linear range of the assay. In our cross-reactivity study, the concentrations at 50% reduction in assay response were within physiological or pathological ranges, and are more representative of the interference occurring in patients' samples. It is accepted that lack of speci¢-city is common to most immunoassays; however, care should be taken when interpreting cross-reactivity data supplied by manufacturers.
Matrix effects
The linear range of the Centaur cortisol assay was reduced by approximately half when standards were prepared in urine reconstruction bu¡er, compared to steroid-free serum (see Fig. 1 ). The recovery of cortisol from the extraction method using spiked normal urine samples, at ¢nal concentrations within the quoted linear range of the assay, was 75% (bu¡er matrix) and 99% (serum matrix). This under-recovery was mirrored in UK NEQAS reports, 4 which demonstrate a recovery of 66.4% for the extraction UFC method compared to an average of 92.7% for serum cortisol, despite both methods using the same assay kit. A similar problem has been described for the Bayer ACS:180, the predecessor of the Centaur analyser, which uses the same UFC extraction method. 5 It was found that the concentration of cortisol measured was dependent on the protein content of the sample matrix. In the same UK NEQAS reports, the ACS:180 direct UFC method demonstrated a recovery of 63.6%, whereas the serum cortisol recovery was 100.5%. The recoveries for other UFC immunoassay methods involved in the scheme were all greater than 90%, and were comparable with the respective serum cortisol methods.
Comparison studies
Patient samples (nˆ31) were analysed in both serum and bu¡er matrices following the Centaur extraction UFC protocol. Linear regression analysis showed a positive and proportional bias for samples prepared in a serum matrix (y) compared to a bu¡er matrix (x), where yˆ1:42x ¡ 65:19.
Of these samples, 27 were suitable for GC-MS analysis. Regression analyses illustrated a positive and proportional bias for samples measured by the Bayer ADVIA Centaur immunoassay (y) compared with GC-MS (x), irrespective of the sample matrix. The overestimation was greater for samples prepared in serum, probably as a result of the increased recovery, at approximately twice that of GC-MS measurements (yˆ2:08x ‡ 124:94 and yˆ1:77x ‡ 84:61, where immunoassay measurements were made in serum and bu¡er matrices, respectively). A Bland-Altman plot 6 con¢rms the positive bias of the Centaur immunoassay method compared to the GC-MS method, with a mean di¡erence of ‡240 nmol/ L (95% con¢dence interval 149-331) (see Fig. 2 ).
Conclusion
The manufacturer's recommended protocol for the Bayer ADVIA Centaur extraction UFC method leads to poor recovery of cortisol from urine samples. Recovery is improved by preparing samples in a steroid-free serum matrix in place of the recommended urine reconstruction bu¡er. Irrespective of the sample matrix used, the assay has poor speci¢city, leading to artefactually high results. Even higher results are obtained when samples are prepared in a serum matrix, revealing the true extent of the lack of speci¢-city. Lack of speci¢city is not unique to the Centaur UFC method; it is a common problem with most immunoassay methods. It could be argued that lack of analytical speci¢city provides a more sensitive screening test for Cushing's syndrome. The cost, however, is decreased diagnostic speci¢city of the test. An apparent elevation in UFC, as determined by immunoassay, could be due to altered cortisol distribution or metabolism, rather than an increase in cortisol production itself, and could lead to extensive over-investigation of false positive cases. Knowledge of the limitations of the method is important when interpreting results. 
